← Back to Search

Social Support Network Intervention for Kidney Cancer

N/A
Waitlist Available
Led By Ken Batai, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eligible participants will be adult Hispanic patients (age 18 or older) who have diagnosis of primary kidney and liver cancer through imaging assessment with CT or MRI at BUMC.
For liver cancer, we will include only HCC patients.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months post enrollment (end of intervention), 12-months, and 18-months
Awards & highlights

Study Summary

This trial will develop and test a social support intervention for Hispanics in Arizona, who have high rates of kidney and liver cancer, to improve health equity. The intervention will incorporate caregivers and other individuals in a patient's social network in survivorship.

Eligible Conditions
  • Kidney Cancer
  • Liver Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months post enrollment (end of intervention), 12-months, and 18-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months post enrollment (end of intervention), 12-months, and 18-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the intervention
Completeness of data collection
Participant adherence to the intervention
+2 more
Secondary outcome measures
Mean and median time to treatment initiation in the control vs. intervention group
Proportion of patients who attend a follow-up imaging assessment after their surgery with hepatologists or urologists in control vs. intervention group
Proportion of patients who attend a scheduled appointment after their surgery with hepatologists or urologists in control vs. intervention group

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
Patients randomized to receive the Social Support Network intervention
Group II: Patient NavigationActive Control1 Intervention
Patients randomized to receive Usual Care (patient navigation)

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
512 Previous Clinical Trials
148,308 Total Patients Enrolled
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,457 Total Patients Enrolled
Ken Batai, PhDPrincipal InvestigatorUniversity of Arizona

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Dec 2025